Finder makes money from featured partners, but editorial opinions are our own.

Why is the Imugene share price under pressure?


Shares in the biotech have been soaring lately, so why is the price struggling today?

Imugene Ltd (ASX:IMU) is among the top traded stocks on the asx on Monday.

Shares in the company are down nearly 5% to 0.538 at the time of writing, compared with market falls of 0.76%.

What is weighing on the Imugene share price?

The healthcare provider is having stellar 2021, especially in the last week, with the company announcing a new partnership with medical giants Merck KGaA and Pfizer.

Under the agreement announced last week, the companies will work together to evaluate the safety and efficacy of Imugene's HER- Vaxx when combined with avelumab in patients with HER-2 postive gastric cancer.

At the time of the announcement Imugene's CEO Leslie Chong noted her excitement to be working with the leading pharmaceuticals.

"HER-Vaxx has shown a tolerable safety profile and encouraging efficacy in patients with metastatic HER-2 positive gastric cancer, and we are looking forward to evaluating HER-Vaxx with avelumab in the perioperative clinical setting," she stated.

"Working together, we're committed to finding ways to address the unmet needs of patients living with cancer."

With the only announcement made to the market being around 'Changes of Director's Interest Notice', it appears much of this morning's sell-off has been investors cashing in on previous good news.

Analyst raise target price

Following the successful announcement of the company's immunotherapy drugs brokers are starting to lift their target price on the stock.

According to Morningstar Quantitative, the share price is undervalued, with a new target price set 8% higher.

Roth Capital has also indicated that the share is a 'strong buy'.

Considering buying Imugene shares?

If you are keen to buy shares in Imugene, consider investing through an online share trading platform.

Do keep in mind that not all platforms offer the same set of stocks. Some only offer US stocks, so make sure to select a platform that offers ASX-listed stocks.

Choose from the dozens available for Australian investors. Compare the features and fees from the plethora of trading platforms available for Australian investors.

Looking for a low-cost online broker to invest in the stock market? Compare share trading platforms to start investing in stocks and ETFs.

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades. Read the Product Disclosure Statement (PDS) and Target Market Determination (TMD) for the product on the provider's website.

Ask a Question

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our 1. Terms Of Service and 6. Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site